{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:56:44Z","timestamp":1790146604870,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:00:00Z","timestamp":1555372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsche BKK, BARMER and Audi BKK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1038\/s41416-019-0453-2","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T23:06:16Z","timestamp":1555369576000},"page":"1015-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Reduction of cervical cancer incidence within a primary HPV screening pilot project (WOLPHSCREEN) in Wolfsburg, Germany"],"prefix":"10.1038","volume":"120","author":[{"given":"Johannes","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Denecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Rothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Reinecke-L\u00fcthge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Mikolajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Ulrich","family":"Petry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,16]]},"reference":[{"key":"453_CR1","first-page":"124","volume":"167","author":"A Meggiolaro","year":"2016","unstructured":"Meggiolaro, A., Unim, B., Semyonov, L., Miccoli, S., Maffongelli, E. & La Torre, G. The role of Pap test screening against cervical cancer: a systematic review and meta-analysis. Clin. Ter. 167, 124\u2013139 (2016).","journal-title":"Clin. Ter."},{"key":"453_CR2","doi-asserted-by":"publisher","first-page":"744","DOI":"10.5306\/wjco.v5.i4.744","volume":"5","author":"SL McGraw","year":"2014","unstructured":"McGraw, S. L. & Ferrante, J. M. Update on prevention and screening of cervical cancer. World J. Clin. Oncol. 5, 744\u2013752 (2014).","journal-title":"World J. Clin. Oncol."},{"key":"453_CR3","first-page":"Cd008587","volume":"8","author":"G Koliopoulos","year":"2017","unstructured":"Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 8, Cd008587 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"453_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/jnci\/djx225","volume":"110","author":"M Schiffman","year":"2017","unstructured":"Schiffman, M., Kinney, W. K., Cheung, L. C., Gage, J. C., Fetterman, B., Poitras, N. E. et al. Relative performance of HPV and cytology components of cotesting in cervical screening. J. Natl. Cancer Inst. 110, 501\u2013508 (2017).","journal-title":"J. Natl. Cancer Inst."},{"key":"453_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s10552-017-0976-x","volume":"29","author":"MI Silver","year":"2018","unstructured":"Silver, M. I., Rositch, A. F., Phelan-Emrick, D. F. & Gravitt, P. E. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap\/HPV cotesting in women aged 30-65 years. Cancer Causes Control 29, 43\u201350 (2018).","journal-title":"Cancer Causes Control"},{"key":"453_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie, M. R., Sharples, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W. et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9, 425\u2013434 (2008).","journal-title":"Lancet Oncol."},{"key":"453_CR7","unstructured":"Beral, V. & Day, N. E. Screening for cervical cancer: is there a place for incorporating tests for the human papillomavirus? IARC Sci. Publ. 263\u2013269 (1992)."},{"key":"453_CR8","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1002\/ijc.30385","volume":"139","author":"SD Isidean","year":"2016","unstructured":"Isidean, S. D., Mayrand, M. H., Ramanakumar, A. V., Gilbert, L., Reid, S. L., Rodrigues, I. et al. Human papillomavirus testing versus cytology in primary cervical cancer screening: end-of-study and extended follow-up results from the Canadian cervical cancer screening trial. Int. J. Cancer 139, 2456\u20132466 (2016).","journal-title":"Int. J. Cancer"},{"key":"453_CR9","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco, G., Dillner, J., Elfstrom, K. M., Tunesi, S., Snijders, P. J., Arbyn, M. et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 383, 524\u2013532 (2014).","journal-title":"Lancet"},{"key":"453_CR10","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","volume":"13","author":"DC Rijkaart","year":"2012","unstructured":"Rijkaart, D. C., Berkhof, J., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W., Heideman, D. A. et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol. 13, 78\u201388 (2012).","journal-title":"Lancet Oncol."},{"key":"453_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18230","volume":"18","author":"HC Kitchener","year":"2014","unstructured":"Kitchener, H. C., Canfell, K., Gilham, C., Sargent, A., Roberts, C., Desai, M. et al. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds. Health Technol. Assess. 18, 1\u2013196 (2014).","journal-title":"Health Technol. Assess."},{"key":"453_CR12","doi-asserted-by":"publisher","first-page":"i4924","DOI":"10.1136\/bmj.i4924","volume":"355","author":"MG Dijkstra","year":"2016","unstructured":"Dijkstra, M. G., van Zummeren, M., Rozendaal, L., van Kemenade, F. J., Helmerhorst, T. J., Snijders, P. J. et al. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands. BMJ 355, i4924 (2016).","journal-title":"BMJ"},{"key":"453_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-379","volume":"13","author":"KU Petry","year":"2013","unstructured":"Petry, K. U., Rinnau, F., Bohmer, G., Hollwitz, B., Luyten, A., Buttmann, N. et al. Annual Papanicolaou screening for 5 years among human papillomavirus-negative women. BMC Cancer 13, 379 (2013).","journal-title":"BMC Cancer"},{"key":"453_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2018.10897","volume":"320","author":"SJ Curry","year":"2018","unstructured":"US Preventive Services Task Force, Curry, S. J., Krist, A. H., Owens, D. K., Barry, M. J., Caughey, A. B. et al. Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement. JAMA 320, 674\u2013686 (2018).","journal-title":"JAMA"},{"key":"453_CR15","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.28783","volume":"135","author":"A Luyten","year":"2014","unstructured":"Luyten, A., Buttmann-Schweiger, N., Luyten, K., Mauritz, C., Reinecke-Luthge, A., Pietralla, M. et al. Early detection of CIN3 and cervical cancer during long-term follow-up using HPV\/Pap smear co-testing and risk-adapted follow-up in a locally organised screening programme. Int. J. Cancer 135, 1408\u20131416 (2014).","journal-title":"Int. J. Cancer"},{"key":"453_CR16","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1038\/sj.bjc.6600918","volume":"88","author":"KU Petry","year":"2003","unstructured":"Petry, K. U., Menton, S., Menton, M., van Loenen-Frosch, F., de Carvalho Gomes, H., Holz, B. et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br. J. Cancer 88, 1570\u20131577 (2003).","journal-title":"Br. J. Cancer"},{"key":"453_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ygyno.2012.10.017","volume":"128","author":"KU Petry","year":"2013","unstructured":"Petry, K. U., Luyten, A. & Scherbring, S. Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany. Gynecol. Oncol. 128, 282\u2013287 (2013).","journal-title":"Gynecol. Oncol."},{"key":"453_CR18","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ygyno.2011.02.033","volume":"121","author":"KU Petry","year":"2011","unstructured":"Petry, K. U., Schmidt, D., Scherbring, S., Luyten, A., Reinecke-Luthge, A., Bergeron, C. et al. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16\/Ki-67 Dual-stained cytology. Gynecol. Oncol. 121, 505\u2013509 (2011).","journal-title":"Gynecol. Oncol."},{"key":"453_CR19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.pvr.2017.10.003","volume":"4","author":"KU Petry","year":"2017","unstructured":"Petry, K. U., Liebrich, C., Luyten, A., Zander, M. & Iftner, T. Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers. Papillomavirus Res. 4, 85\u201389 (2017).","journal-title":"Papillomavirus Res."},{"key":"453_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.2018.7464","volume":"320","author":"GS Ogilvie","year":"2018","unstructured":"Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L. W., Cook, D., Gondara, L. et al. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial. JAMA 320, 43\u201352 (2018).","journal-title":"JAMA"},{"key":"453_CR21","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1200\/JCO.2011.38.8389","volume":"30","author":"PE Castle","year":"2012","unstructured":"Castle, P. E., Glass, A. G., Rush, B. B., Scott, D. R., Wentzensen, N., Gage, J. C. et al. Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up. J. Clin. Oncol. 30, 3044\u20133050 (2012).","journal-title":"J. Clin. Oncol."},{"key":"453_CR22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/S1473-3099(16)30120-7","volume":"16","author":"CM Wheeler","year":"2016","unstructured":"Wheeler, C. M., Skinner, S. R., Del Rosario-Raymundo, M. R., Garland, S. M., Chatterjee, A., Lazcano-Ponce, E. et al. Efficacy, safety, and immunogenicity of the human papillomavirus 16\/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study. Lancet Infect. Dis. 16, 1154\u20131168 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"453_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrclinonc.2015.146","volume":"13","author":"FX Bosch","year":"2016","unstructured":"Bosch, F. X., Robles, C., Diaz, M., Arbyn, M., Baussano, I., Clavel, C. et al. HPV-FASTER: broadening the scope for prevention of HPV-related cancer. Nat. Rev. Clin. Oncol. 13, 119\u2013132 (2016).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"453_CR24","doi-asserted-by":"publisher","first-page":"e1002388","DOI":"10.1371\/journal.pmed.1002388","volume":"14","author":"K Canfell","year":"2017","unstructured":"Canfell, K., Caruana, M., Gebski, V., Darlington-Brown, J., Heley, S., Brotherton, J. et al. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: results of the Compass pilot randomised trial. PLoS Med. 14, e1002388 (2017).","journal-title":"PLoS Med."},{"key":"453_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/jama.2018.10400","volume":"320","author":"J Melnikow","year":"2018","unstructured":"Melnikow, J., Henderson, J. T., Burda, B. U., Senger, C. A., Durbin, S. & Weyrich, M. S. Screening for cervical cancer with high-risk human papillomavirus testing: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 320, 687\u2013705 (2018).","journal-title":"JAMA"},{"key":"453_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4225-9","volume":"18","author":"KU Petry","year":"2018","unstructured":"Petry, K. U., Horn, J., Luyten, A. & Mikolajczyk, R. T. Punch biopsies shorten time to clearance of high-risk human papillomavirus infections of the uterine cervix. BMC Cancer 18, 318 (2018).","journal-title":"BMC Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0453-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-019-0453-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:04:45Z","timestamp":1684616685000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-019-0453-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,16]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1038\/s41416-019-0453-2","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,16]]},"assertion":[{"value":"18 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethics committee of Lower Saxony in Hannover was consulted but approval and\/or trial registration was not required because statutory health insurances Deutsche BKK and Audi BKK use the pilot project as their routine screening program. Participants need to give written consent to be included in WOLPHSCREEN. The written consent includes an agreement that pseudonymised data and left-over material may be used for research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed and approved the final version of the manuscript and consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"WOLPHSCREEN is managed by Klinikum Wolfsburg, the central database is located in the department of gynaecology. The contract between health insurances, gynaecologists in private practice, other partners and Klinikum Wolfsburg encourages the use of WOLPHSCREEN data for research and gives all rights for analyses and publications to the head of the department of obstetrics and gynaecology as leader of the scientific team.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}